- Home
- MESO vs INDV Comparison
MESO vs INDV Comparison
Compare MESO & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESO
- INDV
- Stock Information
- Founded
- MESO 2004
- INDV 1994
- Country
- MESO Australia
- INDV United States
- Employees
- MESO N/A
- INDV 1164
- Industry
- MESO Biotechnology: Biological Products (No Diagnostic Substances)
- INDV Biotechnology: Pharmaceutical Preparations
- Sector
- MESO Health Care
- INDV Health Care
- Exchange
- MESO Nasdaq
- INDV Nasdaq
- Market Cap
- MESO 1.3B
- INDV 1.9B
- IPO Year
- MESO N/A
- INDV N/A
- Fundamental
- Price
- MESO $11.06
- INDV $15.45
- Analyst Decision
- MESO Buy
- INDV Strong Buy
- Analyst Count
- MESO 4
- INDV 2
- Target Price
- MESO $18.00
- INDV $17.50
- AVG Volume (30 Days)
- MESO 205.5K
- INDV 2.2M
- Earning Date
- MESO 08-28-2025
- INDV 07-24-2025
- Dividend Yield
- MESO N/A
- INDV N/A
- EPS Growth
- MESO N/A
- INDV N/A
- EPS
- MESO N/A
- INDV N/A
- Revenue
- MESO $5,670,000.00
- INDV $1,170,000,000.00
- Revenue This Year
- MESO $178.09
- INDV N/A
- Revenue Next Year
- MESO $305.06
- INDV $3.00
- P/E Ratio
- MESO N/A
- INDV N/A
- Revenue Growth
- MESO N/A
- INDV 4.09
- 52 Week Low
- MESO $5.78
- INDV $7.33
- 52 Week High
- MESO $22.00
- INDV $15.88
- Technical
- Relative Strength Index (RSI)
- MESO 50.02
- INDV 68.10
- Support Level
- MESO $10.32
- INDV $14.93
- Resistance Level
- MESO $10.86
- INDV $15.88
- Average True Range (ATR)
- MESO 0.35
- INDV 0.48
- MACD
- MESO 0.00
- INDV 0.01
- Stochastic Oscillator
- MESO 45.04
- INDV 75.72
About MESO Mesoblast Limited
Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.